Search Results - "Banzhoff, A"

Tick-borne encephalitis (TBE) vaccination: Applying the most suitable vaccination schedule by Schöndorf, I, Beran, J, Cizkova, D, Lesna, V, Banzhoff, A, Zent, O

“…Abstract Tick-borne encephalitis (TBE) is caused by an arthropod-borne virus, belonging to the family of Flaviviridae. In case of disease, which can lead to…”
Get full text

Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients by de Roux, A., Marx, A., Burkhardt, O., Schweiger, B., Borkowski, A., Banzhoff, A., Pletz, M.W.R., Lode, H.

“…The influence of steroids on the antibody response to a MF59-adjuvanted influenza vaccine in elderly COPD patients has not been studied previously. In the…”
Get full text

Cross subclade immunity after one-year booster immunization with MF59®-adjuvanted A/H5N1 influenza vaccine in 6 month to 17 year-old children by Vesikari, T, Karvonen, A, Montomoli, E, Banzhoff, A, Tsai, T

Get full text

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine by BRIGGS, D. J, BANZHOFF, A, NICOLAY, U, SIRIKWIN, S, DUMAVIBHAT, B, TONGSWAS, S, WASI, C

“…Although the introduction of tissue culture vaccines for rabies has dramatically improved the immunogenicity and safety of rabies vaccines, they are often…”
Get full text

Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation by Rendi-Wagner, Pamela, Kundi, M., Zent, O., Banzhoff, A., Jaehnig, P., Stemberger, R., Dvorak, G., Grumbeck, E., Laaber, B., Kollaritsch, H.

“…This study investigated the immune response and safety in 430 adults, when boosted more than 3 years after primary or booster TBE immunisation as measured by…”
Get full text

Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer by Zent, O, Banzhoff, A, Hilbert, A.K, Meriste, S, Słuzewski, W, Wittermann, Ch

“…A total of 3559 children aged 1–11 years were enrolled in two clinical studies to evaluate immunogenicity and safety of a new pediatric tick-borne encephalitis…”
Get full text

Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly by Brauer, V.F.H, Laghi-Pasini, F, Capecchi, P.L, Gentile, C, di Giovanni, P, Staniscia, T, Montomoli, E, Hilbert, A, Tilman, S, Durando, P, Sticchi, L, Gasparini, R, Banzhoff, A

Get full text

Diphtheria booster vaccination: one or two injections? by Nicolay, U, Girgsdies, O.-E, Banzhoff, A, Hundt, E, Jilg, W

“…In a prospective, controlled, randomized, multicenter study the immunogenicity and tolerance of a single vaccination (day 0) and two (day 0, 28) booster…”
Get full text

EFFECTIVENESS OF AN INFLUENZA VACCINE USED IN POLAND IN THE 1998-1999 INFLUENZA SEASON by Banzhoff, A., Banzhoff, Angelika, Kaniok, Wojciech, Muszer, Adam

“…The aim of this study was to evaluate the effectiveness of the influenza vaccine used at the Proelmed Medical Center, Poland during the influenza season…”
Get full text

Challenges to Academic Integrity: Identifying the Factors Associated With the Cheating Chain by Bernardi, Richard A., Banzhoff, Caitlin A., Martino, Abigail M., Savasta, Katelyn J.

“…This study examined whether seeing other students cheat in examinations and/or knowing students who routinely cheat in examinations associates with other…”
Get full text

Recent advances in the prevention of meningococcal B disease: Real evidence from 4CMenB vaccination by Martinón-Torres, F., Banzhoff, A., Azzari, C., de Wals, P., Marlow, R., Marshall, H., Pizza, M., Rappuoli, R., Bekkat-Berkani, R.

“…The 4CMenB vaccine confers protection against serogroup B invasive meningococcal disease (MenB IMD). Licensed worldwide based on immunogenicity and safety…”
Get full text

A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis by Banzhoff, Angelika, Nacci, Pantaleo, Podda, Audino

“…The elderly are at a higher risk of morbidity and mortality associated with influenza infection than younger adults, but get less protection from conventional…”
Get more information

Fatal varicella in a 5-year-old boy by BANZHOFF, A, SCHAUER, U, RIEDEL, F, GAHR, M, RIEGER, C. H. L

Get full text

From a pathogen's genome to an effective vaccine: the four-component meningococcal serogroup B vaccine by Abad, R, Martinón-Torres, F, Santolaya, M E, Banzhoff, A, González-Inchausti, C, Graña, M G, Vázquez, J A

“…Invasive meningococcal disease (IMD), caused by the bacterium Neisseria meningitidis, entails significant mortality and morbidity. Disease incidence is highest…”
Get full text

Salivary anti-RSV IgA antibodies and respiratory infections during the first year of life in atopic and non-atopic infants by Banzhoff, A, Dulleck, A, Petzoldt, S, Rieger, C H

“…Salivary SIgA antibodies against RS virus were studied in 105 children during the first year of life. The infants were divided into groups according to their…”
Get more information

Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals by Quiambao, Beatriz P., Dimaano, Efren M., Ambas, Cristina, Davis, Rolan, Banzhoff, Angelika, Malerczyk, Claudius

“…Purified chick embryo cell rabies vaccine (PCECV) administered as 0.1 ml intradermally according to the Thai Red Cross (TRC) regimen could reduce the cost of…”
Get full text

Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): An immunogenic, cost-effective and practical regimen by Ambrozaitis, Arvydas, Laiškonis, Alvydas, Balčiuniene, Ligita, Banzhoff, Angelika, Malerczyk, Claudius

“…Currently, two intradermal (ID) regimens for rabies post-exposure prophylaxis (PEP) are recommended by WHO and used in countries where approved by national…”
Get full text

Potency requirements of rabies vaccines administered intradermally using the Thai Red Cross regimen: investigation of the immunogenicity of serially diluted purified chick embryo cell rabies vaccine by Beran, Jiri, Honegr, Karel, Banzhoff, Angelika, Malerczyk, Claudius

“…To determine the minimum vaccine potency per intradermal dose required to elicit an adequate immune response using the Thai Red Cross (TRC) regimen…”
Get full text

Avances recientes en la prevención de la enfermedad meningocócica B: evidencia real de la vacunación con 4CMenB by Martinón-Torres, F., Banzhoff, A., Azzari, C., de Wals, P., Marlow, R., Marshall, H., Pizza, M., Rappuoli, R., Bekkat-Berkani, R.

“…4CMenB es una vacuna que confiere protección frente a la enfermedad meningocócica invasiva por el serogrupo B (EMI por MenB). Autorizada en todo el mundo a…”
Get full text

Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults by Zent, Olaf, Beran, Jiri, Jilg, Wolfgang, Mach, Tomasz, Banzhoff, Angelika

“…Objective: To evaluate immunogenicity and safety of a polygeline-free tick-born encephalitis (TBE) vaccine in a clinical program. Method: A total of 3118…”
Get full text